Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders
kaboompics / Pixabay

Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders

In a press release from late January 2021, biopharmaceutical company Seelos Therapeutics, Inc. ("Seelos") announced the issuance of an Australian patent for Trehalose (SLS-005). The patent (#2019204513) centers around the…

Continue Reading Australian Patent Issued for Trehalose (SLS-005) for Neurodegenerative Disorders

Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases

According to a recent article in MedicalXpress, researchers in Japan led by Dr. Shinsuke Ishigaki and his team at Nagoya University, have identified new molecular details about tau’s activity. Alzheimer’s,…

Continue Reading Researchers at Nagoya University are One Step Closer to Unraveling the Tau Mystery in Neurodegenerative Diseases
Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets
source: pixabay.com

Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets

  As of right now, there are no treatments for Alzheimer's disease, a progressive neurodegenerative disorder. However, that may soon change. A study led by UCLA researchers identified potential drug…

Continue Reading Analyzing the Alzheimer’s Disease Proteome Develops New Drug Targets
Study Delineates Six Stages of Progressive Supranuclear Palsy
https://pixabay.com/en/nerve-cell-neuron-brain-neurons-2213009/

Study Delineates Six Stages of Progressive Supranuclear Palsy

A recent study published in Acta Neuropathologica discusses the importance of symptom and health management for people with progressive supranuclear palsy. The rare condition, which causes neuronal degeneration, has no cure. But…

Continue Reading Study Delineates Six Stages of Progressive Supranuclear Palsy
RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy
Source: Pixabay.com

RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy

  According to BioSpace, healthcare technology company RDMD has raised $14 million in Series A financing, and developed a partnership with UCB. In addition to growing their platform to discuss…

Continue Reading RDMD Gets $14 Million in Financing, Partners with UCB to Research Progressive Supranuclear Palsy
Two Companies Collaborate on Progressive Supranuclear Palsy Clinical Trial
TeroVesalainen / Pixabay

Two Companies Collaborate on Progressive Supranuclear Palsy Clinical Trial

According to a story from BioPortfolio, the biopharmaceutical company AlzProtect recently announced that PAREXEL Biotech, which is a subsidiary of PAREXEL International Corporation, will be expected to conduct a Phase…

Continue Reading Two Companies Collaborate on Progressive Supranuclear Palsy Clinical Trial

This Foundation is Offering Cash Rewards for Breakthroughs in Progressive Supranuclear Palsy

According to a story from Xconomy, the Rainwater Foundation, which was first founded in the 90s by Texas billionaire Richard Rainwater, is offering cash rewards to the tune of $250,000…

Continue Reading This Foundation is Offering Cash Rewards for Breakthroughs in Progressive Supranuclear Palsy
Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy
rawpixel / Pixabay

Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy

The Parkinson’s Institute and Clinical Center and Retrotope are teaming up to study a potential new therapy for patients with progressive supranuclear palsy. For more information about this collaboration, you…

Continue Reading Two Organisations are Collaborating Over a Potential Drug for Progressive Supranuclear Palsy
Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease
nuzree / Pixabay

Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease

According to a public release from University of Texas Health Center at San Antonio on eurekalert.org, research using fruit fly tauopathy disease models has revealed a genetic "copy-paste" activity that…

Continue Reading Tauopathy Fruit Fly Model Reveals Abnormal Genetic Activity Relevant to Neurodegenerative Disease
ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
qimono / Pixabay

ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases

Prana Biotechnology has announced that it has begun recruiting healthy volunteers for its Phase I clinical trial of the experimental drug PBT434. The drug is thought to affect processes linked…

Continue Reading ICYMI: Recruitment Has Begun For a Phase I Clinical Trial of A Drug Designed to Treat Parkinsonian Diseases
Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
source: pixabay.com

Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy

According to a story from businesswire.com, the company Prana Biotechnology Ltd recently announced that it is beginning the recruitment process for its Phase 1 clinical trial of its investigational product…

Continue Reading Phase 1 Trial Set to Begin For Experimental Therapy For Multiple System Atrophy and Progressive Supranuclear Palsy
This Gene Could Play a Major Role in Progressive Supranuclear Palsy
source: pixabay.com

This Gene Could Play a Major Role in Progressive Supranuclear Palsy

According to a story from asianscientist.com, a group of Japanese researchers have managed to unearth a genetic mutation that is associated with progressive supranuclear palsy. The discovery is helping scientists…

Continue Reading This Gene Could Play a Major Role in Progressive Supranuclear Palsy
Reporter Fundraises For Progressive Supranuclear Palsy Research
https://pixabay.com/en/news-information-announcement-1980105/

Reporter Fundraises For Progressive Supranuclear Palsy Research

Adam Murphy, a reporter for CBS46 learned of his mother's diagnosis of Progressive Supranuclear Palsy, PSP, in 2010 and decided to use his reporter platform to help her, originally reported…

Continue Reading Reporter Fundraises For Progressive Supranuclear Palsy Research